Order Article Reprints

Chisholm J, Mandeville H, Adams M, Minard-Collin V, Rogers T, Kelsey A, Shipley J, van Rijn RR, de Vries I, van Ewijk R, et al. Frontline and Relapsed Rhabdomyosarcoma (FaR-RMS) Clinical Trial: A Report from the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG). Cancers. 2024; 16(5):998. https://doi.org/10.3390/cancers16050998

Chisholm, Julia, Henry Mandeville, Madeleine Adams, Veronique Minard-Collin, Timothy Rogers, Anna Kelsey, Janet Shipley, Rick R. van Rijn, Isabelle de Vries, Roelof van Ewijk, and et al. 2024. "Frontline and Relapsed Rhabdomyosarcoma (FaR-RMS) Clinical Trial: A Report from the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG)" Cancers 16, no. 5: 998. https://doi.org/10.3390/cancers16050998

Chisholm, J., Mandeville, H., Adams, M., Minard-Collin, V., Rogers, T., Kelsey, A., Shipley, J., van Rijn, R. R., de Vries, I., van Ewijk, R., de Keizer, B., Gatz, S. A., Casanova, M., Hjalgrim, L. L., Firth, C., Wheatley, K., Kearns, P., Liu, W., Kirkham, A., ... Jenney, M. (2024). Frontline and Relapsed Rhabdomyosarcoma (FaR-RMS) Clinical Trial: A Report from the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG). Cancers, 16(5), 998. https://doi.org/10.3390/cancers16050998